Sequoia Capital China has participated in a $16-million Series A round for US-based drug discovery company Cullgen Inc, according to a statement.
Chinese healthcare-focused investment firm HighLight Capital also participated in the funding round. Following the investment, Sequoia will get a seat on Cullgen’s board.